JP2023551340A5 - - Google Patents
Info
- Publication number
- JP2023551340A5 JP2023551340A5 JP2023533363A JP2023533363A JP2023551340A5 JP 2023551340 A5 JP2023551340 A5 JP 2023551340A5 JP 2023533363 A JP2023533363 A JP 2023533363A JP 2023533363 A JP2023533363 A JP 2023533363A JP 2023551340 A5 JP2023551340 A5 JP 2023551340A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- methanone
- dihydro
- benzo
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20206226 | 2020-12-01 | ||
| FI20206226 | 2020-12-01 | ||
| PCT/FI2021/050828 WO2022117920A1 (en) | 2020-12-01 | 2021-11-30 | 2,3-dihydro-4h-benzo[b][1,4]oxazin-4-yl)(5-(phenyl)-pyridin-3-yl)methanone derivatives and similar compounds as cyp11a1 inhibitors for the treatment of prostate cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023551340A JP2023551340A (ja) | 2023-12-07 |
| JP2023551340A5 true JP2023551340A5 (https=) | 2024-12-06 |
| JP7824953B2 JP7824953B2 (ja) | 2026-03-05 |
Family
ID=78827916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533363A Active JP7824953B2 (ja) | 2020-12-01 | 2021-11-30 | 前立腺がんの治療のためのｃｙｐ１１ａ１阻害薬としての２，３－ジヒドロ－４ｈ－ベンゾ［ｂ］［１，４］オキサジン－４－イル）（５－（フェニル）－ピリジン－３－イル）メタノン誘導体および類似化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240124431A1 (https=) |
| EP (1) | EP4255902B1 (https=) |
| JP (1) | JP7824953B2 (https=) |
| KR (1) | KR20230117187A (https=) |
| CN (1) | CN116724034A (https=) |
| AU (1) | AU2021391977A1 (https=) |
| CA (1) | CA3200556A1 (https=) |
| MX (1) | MX2023006290A (https=) |
| WO (1) | WO2022117920A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202409023A (zh) * | 2022-07-14 | 2024-03-01 | 美商富曼西公司 | 除草苯并𠯤 |
| CN121002012A (zh) * | 2023-03-29 | 2025-11-21 | 西藏海思科制药有限公司 | Cyp11a1抑制剂及其用途 |
| CN121039123A (zh) * | 2023-04-21 | 2025-11-28 | 西藏海思科制药有限公司 | Cyp11a1抑制剂及其用途 |
| WO2025021182A1 (en) * | 2023-07-27 | 2025-01-30 | Acerand Therapeutics (Hong Kong) Limited | Cyp11a1 inhibitors |
| WO2025051216A1 (zh) * | 2023-09-08 | 2025-03-13 | 深圳众格生物科技有限公司 | 一种cyp11a1抑制剂、其制备方法及其应用 |
| WO2025168117A1 (zh) * | 2024-02-08 | 2025-08-14 | 盛睿泽华医药科技（苏州）有限公司 | 一种多环化合物及其制备方法和应用 |
| WO2026002207A1 (en) * | 2024-06-28 | 2026-01-02 | Acerand Therapeutics (Hong Kong) Limited | Heterocyclic compounds as cyp11a1 inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8759379B2 (en) * | 2008-01-04 | 2014-06-24 | Gilead Sciences, Inc. | Inhibitors of cytochrome P450 |
| AR110412A1 (es) | 2016-12-22 | 2019-03-27 | Orion Corp | Inhibidores de la cyp11a1 |
-
2021
- 2021-11-30 US US18/255,218 patent/US20240124431A1/en active Pending
- 2021-11-30 MX MX2023006290A patent/MX2023006290A/es unknown
- 2021-11-30 JP JP2023533363A patent/JP7824953B2/ja active Active
- 2021-11-30 CA CA3200556A patent/CA3200556A1/en active Pending
- 2021-11-30 KR KR1020237022283A patent/KR20230117187A/ko active Pending
- 2021-11-30 AU AU2021391977A patent/AU2021391977A1/en active Pending
- 2021-11-30 CN CN202180080720.1A patent/CN116724034A/zh active Pending
- 2021-11-30 WO PCT/FI2021/050828 patent/WO2022117920A1/en not_active Ceased
- 2021-11-30 EP EP21823336.9A patent/EP4255902B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023551340A5 (https=) | ||
| KR102769567B1 (ko) | 단백질 키나제 억제제로서의 벤조락탐 화합물 | |
| JP6126613B2 (ja) | アミノキナゾリン誘導体及びそれらの塩並びに使用方法 | |
| ES2739697T3 (es) | Nuevos compuestos y derivados de espiro[3H-indol-3,2-pirrolidin]-2(1H)-ona como inhibidores de MDM2-p53 | |
| CN111902415A (zh) | 药学化合物 | |
| CA2571627A1 (en) | Substituted aryl-amine derivatives and methods of use | |
| WO2017060431A1 (en) | Spiro[3h-indole-3,2´-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors | |
| TW200848031A (en) | Oxazolidinone antibiotics | |
| TW200940063A (en) | 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use | |
| TW201139435A (en) | Substituted naphthyridines and their use as medicaments | |
| WO2015155332A1 (en) | Spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one derivatives and their use as mdm2-p53 inhibitors | |
| JP2008507539A5 (https=) | ||
| ES3061522T3 (en) | Khk inhibitors | |
| AU2021313150A1 (en) | Indole compounds as androgen receptor modulators | |
| TW200904817A (en) | Compounds and uses thereof | |
| WO2014180182A1 (zh) | [1,2,4]三唑并[4,3-a]吡啶类衍生物，其制备方法或其在医药上的应用 | |
| US20240018115A1 (en) | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease | |
| WO2019094319A1 (en) | Pyrrolopyrazine derivatives as alpha v integrin inhibitors | |
| WO2014193647A2 (en) | Alkenyl compounds and methods of use | |
| JP6454346B2 (ja) | 芳香族複素環式化合物及び医薬におけるその応用 | |
| RU2023117290A (ru) | ПРОИЗВОДНЫЕ (2,3-ДИГИДРО-4H-БЕНЗО[b][1,4]ОКСАЗИН-4-ИЛ)(5-(ФЕНИЛ)-ПИРИДИН-3-ИЛ)МЕТАНОНА И АНАЛОГИЧНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ CYP11A1 ДЛЯ ЛЕЧЕНИЯ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ | |
| US12441725B2 (en) | ISO-citrate dehydrogenase (IDH) inhibitor | |
| JP2024533046A5 (https=) | ||
| TWI690528B (zh) | 稠環雙環吡啶基衍生物 | |
| BR112018007526B1 (pt) | Compostos de benzolactama, composição farmacêutica e combinação contendo os mesmos, método de preparação, e, seus usos como inibidores de proteína quinase |